Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

Indian generic drugmaker Dr Reddy's Laboratories on Thursday said it was optimistic about the Donald Trump administration, as it believes the country would have an edge amid tensions between the ...

Authorities in China are investigating reports of quality problems with some drugs eligible for distribution through the ...

"China has historically suffered greatly from the harms of drugs, which gives us a profound understanding and resolute attitude toward drug issues, particularly concerning new psychoactive ...

China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why ...

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly ...

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.